| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Drug Development | Executive VP, Drug Development
2 companies
Manhard Kimberly serves as an EVP, Drug Development at HRTX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 20 sells. Those positions are worth an estimated $788K at current prices.
Historically, Manhard Kimberly's trades have earned a strong insider score of 80/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +74.4%.
The biggest single holding is INBX (~$788K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 7,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | INBX Inhibrx Biosciences, Inc. | Director | Sell | 1,500 | $109.03 | $163,542.50 | -16.7% | - | - | |
| Sep 9, 2026 | INBX Inhibrx Biosciences, Inc. | Director | Sell | 1,000 | $115.47 | $115,467.50 | -10.0% | - | - | |
| Aug 28, 2024 | INBX Inhibrx Biosciences, Inc. | Director | Buy | 10,000 | $13.98 | $139,800.00 | New | +10.7% | +99.7% | |
| May 3, 2022 | HRTX Heron Therapeutics, Inc. /de/ | EVP, Drug Development | Sell | 1,504 | $4.76 | $7,153.63 | -12.2% | -42.3% | -50.9% | |
| May 3, 2021 | HRTX Heron Therapeutics, Inc. /de/ | EVP, Drug Development | Sell | 1,529 | $17.66 | $27,008.71 | -48.3% | -28.8% | -72.6% | |
| Dec 22, 2020 | HRTX Heron Therapeutics, Inc. /de/ | EVP, Drug Development | Sale+OE | 10,000 | $20.00 | $200,000.00 | -100% | - | - | |
| May 1, 2020 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sell | 1,158 | $13.97 | $16,175.75 | -100% | - | - | |
| Nov 29, 2019 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sale+OE | 24,000 | $26.00 | $624,000.00 | -100% | - | - | |
| May 1, 2019 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sell | 1,109 | $18.86 | $20,918.07 | -100% | - | - | |
| Nov 2, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sell | 494 | $30.62 | $15,124.95 | -100% | - | - |